These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 11119911

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
    Fabrega AJ, Corwin CL, Hunsicker L.
    Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
    Tojimbara T, Kimikawa M, Nakajima I, Sato S, Nakamura M, Ishida H, Tanabe K, Koyama I, Utsumi K, Sannomiya A, Tsuji K, Fuchinoue S, Agishi T.
    Transplant Proc; 1999 Nov; 31(7):2763-4. PubMed ID: 10578282
    [No Abstract] [Full Text] [Related]

  • 47. Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation.
    Salizzoni M, Cavallari A, Risaliti A, Filipponi F, Gerunda GE, Forti D, Fassati LR, Cillo U, Castagneto M, Valente U, Tisone G.
    Transplant Proc; 2001 May; 33(3):2258-62. PubMed ID: 11377521
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G, Rosen A, Loreto-Grand B, Burke G, Siquijor A, Luque C, Esquenazi V, Miller J.
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
    Scott-Douglas N, Zimmerman D, Klassen J.
    Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
    Rossi G, Reggiani P, Orsenigo R, Leoni L, Caccamo L, Doglia M, Gatti S, Maggi U, Paone G, Galmarini D, Fassati LR.
    Transplant Proc; 1998 Jun; 30(4):1391-3. PubMed ID: 9636562
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression.
    Washburn WK, Shaffer D, Simpson MA, Conway P, Madras PN, Monaco AP.
    Transplant Proc; 1996 Apr; 28(2):1015-6. PubMed ID: 8623214
    [No Abstract] [Full Text] [Related]

  • 60. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP, Mueller AR, Zytowski M, Lobeck H, Neuhaus P.
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.